Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 28 July 2006. doi:10.1136/adc.2006.096297
Archives of Disease in Childhood - Fetal and Neonatal Edition 2007;92:F44-F45
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2006.096297v1
92/1/F44    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carmichael, A
Right arrow Articles by Kempley, S T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carmichael, A
Right arrow Articles by Kempley, S T
Topic Collections
Right arrowRelated Article

ORIGINAL ARTICLE

Critical dependence of acetate thermal mattress on gel activation temperature

A Carmichael, S McCullough, S T Kempley

Neonatal Transfer Service for London, Barts and the London NHS Trust, London, UK

Correspondence to:
Correspondence to:
S T Kempley
Royal London Hospital, Whitechapel, London E1 1BB, UK;steve.kempley{at}bartsandthelondon.nhs.uk

Background: Sodium acetate gel mattresses provide an active method of warming patients through release of latent heat of crystallisation. They can be used as an adjunct to incubator care or as an exclusive heat source.

Objective: To determine activation temperatures of the Transwarmer mattress needed to achieve plateau temperatures of 38–42°C.

Design and setting: In vitro testing of mattress temperature.

Methods and outcome measures: Transwarmer mattresses were activated at initial temperatures ranging from 5 to 40°C. Mattress temperature was recorded up to 4 h to determine peak and plateau temperatures. Peak and plateau temperatures achieved by the mattress were related to the initial starting temperature.

Results: The starting temperature of the mattress was strongly correlated with peak and plateau temperature (r = 0.99, p<0.001). To achieve the target temperature of 38–42°C, the Transwarmer mattress requires activation between 19.2°C and 28.3°C. A temperature of 37°C could be generated by activation at 17°C.

Conclusions: Safe use of this device is critically dependent on gel temperature at the point of activation. To ensure warming of a hypothermic neonatal patient without running any risk of burns, the mattress should be activated with a gel temperature between 19°C and 28°C.



Related Article

Fantoms
Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2007 92: F1. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health